Mode
Text Size
Log in / Sign up

Bacteriophages show promise as targeted anti-caries agents in systematic reviewBacteriophages Show Promise Against Cavities

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider phage-based caries interventions as an emerging, preclinical strategy; current evidence is theoretical.

This systematic review summarizes current advances in phage-based interventions for the prevention and treatment of dental caries. It covers phages targeting cariogenic bacteria such as Streptococcus mutans and Actinomyces spp., as well as phage-derived enzymes like endolysins and holins. The review describes mechanisms including direct bacterial lysis and biofilm disassembly.

The authors synthesize findings from preclinical studies involving phages such as φAPCM01, SMHBZ8, and Av-1. No pooled effect sizes are reported, as the evidence is primarily mechanistic and descriptive. The review highlights the potential of phages to selectively target cariogenic pathogens while preserving the oral microbiome.

Limitations include the absence of clinical trial data; the review provides a theoretical foundation rather than evidence from human studies. Safety outcomes, sample sizes, and comparators are not reported. The authors do not discuss specific gaps or conflicts of interest.

For clinicians, this review offers background on an emerging strategy but does not support immediate practice changes. Phage-based caries interventions remain experimental, and current management should continue to rely on established preventive and therapeutic measures.

How this fits prior evidence

This systematic review extends prior coverage of antimicrobial strategies for oral disease, such as berberine's effects on oral mucosal conditions, by focusing on bacteriophages as a targeted approach against cariogenic bacteria. It contrasts with the narrative review framing oral diseases as host-microbiome-immune imbalances, offering a pathogen-specific intervention. The review also complements prior findings on sugar's role in caries by proposing a method to selectively eliminate cariogenic species without disrupting the broader microbiome.

A new review of research suggests that bacteriophages, viruses that infect and kill bacteria, may offer a new way to prevent and treat dental cavities. Cavities are caused by bacteria like Streptococcus mutans that form plaque and produce acid that damages teeth. Current treatments rely on antibiotics or fluoride, but these can harm helpful mouth bacteria or lead to resistance.

The review looked at several phage-based approaches, including phages called φAPCM01, SMHBZ8, and Av-1, as well as enzymes produced by phages. These phages target cavity-causing bacteria directly, breaking them open (lysis) or breaking down the sticky biofilm they create. This could allow for a more targeted treatment that spares the rest of the mouth's microbiome.

It is important to note that this is a review of early laboratory research, not a clinical trial in people. No safety data or side effects were reported, and the studies were not done in patients. The findings provide a theoretical foundation for future treatments, but much more research is needed before phages could become a cavity treatment.

For now, the best way to prevent cavities remains brushing with fluoride toothpaste, flossing, and regular dental visits. This research is a promising step, but it is not ready for your dentist's office.

What this means for you:
Phage-based treatments are a promising early idea for cavities, but not yet proven in humans.

Common questions

What are bacteriophages?

Bacteriophages are viruses that naturally infect and kill bacteria. They are being studied as a way to target specific harmful bacteria without affecting helpful ones.

How would phages work against cavities?

Phages can kill cavity-causing bacteria like Streptococcus mutans directly, or use enzymes to break down the sticky biofilm (plaque) that protects them.

Are phage treatments for cavities available now?

No. This review is based on early laboratory research. Phage treatments for cavities are not yet tested in humans and are not available at the dentist.

Is this treatment safe?

The review did not report any safety data. More research is needed to know if phage treatments are safe for use in people's mouths.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Dental caries, a globally prevalent chronic infectious disease, is driven by microbial dysbiosis of dental biofilm, involving multiple caries-associated colonizers. Conventional broad-spectrum antimicrobials and fluoride-based formulations often disrupt the commensal oral microbiota, contributing to antimicrobial resistance and imbalance of the oral ecosystem. In contrast, bacteriophage (phage) therapy has emerged as a promising precision strategy for caries control due to its high specificity, minimal off-target effects, and biofilm-disrupting capacity. Our review systematically summarizes recent advances in phage-based interventions for caries prevention and treatment. It describes the diversity and distribution of the oral phageome and its role in regulating oral microbial homeostasis. The review further details phages targeting key cariogenic bacteria, including S. mutans (e.g., φAPCM01, SMHBZ8), Actinomyces spp. (e.g., Av-1), and related phage enzymes. Core anti-bacterial and anti-biofilm mechanisms of oral phage are elucidated, such as direct bacterial lysis mediated by endolysins and holins, and inhibition and disassembly of biofilms through multiple mechanisms. Strategies for applying phages in caries management are also discussed, encompassing phage cocktails, combination therapies with conventional antimicrobials, and development of advanced delivery systems. Finally, current challenges and future directions of phage therapy are addressed. Overall, this review provides a comprehensive theoretical foundation for developing targeted, oral microbiome-friendly phage-based strategies against dental caries.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.